| Titolo |
Pubblicato in |
Anno |
| The diagnosis of benign prostatic obstruction: validation of the young academic urologist clinical nomogram |
UROLOGY |
2015 |
| Editorial Comment from Dr Presicce et al. to Emerging links between non-neurogenic lower urinary tract symptoms secondary to benign prostatic obstruction, metabolic syndrome and its components. a systematic review |
INTERNATIONAL JOURNAL OF UROLOGY |
2015 |
| Patient's adherence on pharmacological therapy for benign prostatic hyperplasia (BPH)-associated lower urinary tract symptoms (LUTS) is different. Is combination therapy better than monotherapy |
BMC UROLOGY |
2015 |
| Patients with prostatic inflammation undergoing transurethral prostatic resection have a larger early improvement of storage symptoms |
UROLOGY |
2015 |
| Transrectal-ultrasound prostatic biopsy preparation. Rectal enema vs. mechanical bowel preparation |
CENTRAL EUROPEAN JOURNAL OF UROLOGY |
2015 |
| TRENDS IN THE USE OF PARTIAL NEPHRECTOMY FOR CT1 RENAL TUMORS: ANALYSIS OF A 10-YR EUROPEAN MULTICENTER DATASET |
THE JOURNAL OF UROLOGY |
2015 |
| Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis. |
BJU INTERNATIONAL |
2015 |
| Re: Christian Gratzke, Alexander Bachmann, Aurelien Descazeaud, et al. EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2014.12.038. |
EUROPEAN UROLOGY |
2015 |
| A review of detrusor overactivity and the overactive bladder after radical prostate cancer treatment. |
BJU INTERNATIONAL |
2015 |
| Central obesity is predictive of persistent storage lower urinary tract symptoms (LUTS) after surgery for benign prostatic enlargement: results of a multicentre prospective study. |
BJU INTERNATIONAL |
2015 |
| Benign prostatic hyperplasia in 2014: Innovations in medical and surgical treatment. |
NATURE REVIEWS. UROLOGY |
2015 |
| Re: association between metabolic syndrome and severity of lower urinary tract symptoms: an observational study in a 4666 European men cohort. |
EUROPEAN UROLOGY |
2015 |
| Corrigendum to "Quality of Life and Sexual Health in the Aging of PCa Survivors". |
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY |
2015 |
| Current Pharmacological Treatment for Male LUTS due to BPH: Dutasteride or Finasteride? |
CURRENT DRUG TARGETS |
2015 |
| Clinical research office of the Endourological Society Global GreenLight Laser Study. outcomes from a contemporary series of 713 patients |
INTERNATIONAL JOURNAL OF UROLOGY |
2015 |
| Tolterodine in the treatment of male LUTS |
CURRENT UROLOGY REPORTS |
2015 |
| The management of overactive bladder: Percutaneous tibial nerve stimulation, sacral nerve stimulation, or botulinum toxin? |
CURRENT OPINION IN UROLOGY |
2015 |
| The continuing Story of the Cost-Effectiveness of Photoselective Vaporization of the Prostate versus Transuretheral Resection of the Prostate for the Treatment of Symptomatic Benign Prostatic Obstruction |
VALUE IN HEALTH |
2015 |
| Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4). A double-blind, multicentre, phase 3, randomised, placebo-controlled trial |
THE LANCET ONCOLOGY |
2015 |
| The Current Indications and the Benefits of Combining a β3-Agonist with an Anticholinergic for the Treatment of OAB |
CURRENT DRUG TARGETS |
2015 |
